We are delighted to share that Mantra Pharma proudly took part in the 2024 Noeudvembre campaign, organized by PROCURE. Held throughout November, this annual effort is dedicated to raising public awareness and funding critical research in the fight against prostate cancer, the most common cancer among men.

As part of our commitment to responsible medication disposal, we are proud to support Medications Return Programs managed by Health Products Stewardship Association (HPSA). These programs provide a safe and convenient way for consumers to dispose of unused or expired household medications in an environmentally responsible manner.

Canada, as many other countries, has taken serious steps to address and eradicate from its supply chains exploitative practices such as forced labour and child labour. Mantra Pharma Inc. (“Mantra Pharma”) is committed to respect the human rights and adopt a zero-tolerance approach to forced labour and child labour and act ethically in all its business relationships.

BROSSARD, QC, February 8, 2024 – At the height of the season when respiratory viruses are on the rise in the population, Mantra is solidifying its supply of an oral antibiotic whose shortage last year caused major issues for medical staff and parents of sick children.

Brossard, January 5, 2024—People suffering from dyslipidemia, a frequently trivialized and even neglected silent disease, often underestimate its impact. Although drug therapy alternatives are available on the market, Mantra Pharma is pleased to inform people with dyslipidemia that a new natural solution is now available to help them optimize their lipid profile and improve their cardiovascular health. The product, named Cardiosmile, is now available behind the counter in Quebec pharmacies.

Brossard, November 7, 2023 – Mantra Pharma, a company that develops and markets generic drugs and over-the-counter products, has taken another step to achieve its growth objectives by signing an agreement to bring in Marcan Pharmaceuticals, a Canadian pharmaceutical company, as a shareholder.

BROSSARD, May 16, 2023— Mantra Pharma maintains impressive growth completing 39 product launches, including all strengths, in the past 16 months. A remarkable performance for a Quebec company competing in a market once dominated by major international pharmaceutical corporations.

BROSSARD, December 16, 2022 - Following an increase in cases of respiratory viruses, Canada is currently experiencing supply issues for an oral antibiotic for children, the CLAVULIN® from GSK. This shortage is being alleviated by the arrival of the very first generic drug from a Quebec company: M-Amoxi Clav offered by Mantra Pharma.

BROSSARD, 21 September, 2022 - Since the beginning of 2022, Mantra Pharma has launched several new products, planning to offer no less than six new molecules by December, one of which is M-Apixaban. The Quebec-based pharmaceutical company is ready for a very busy fall and has increased its portfolio to nearly 100 products.

LÉVIS, 10 January, 2021 - It is with great pride that Mantra Pharma’s Lévis team opened its new warehouse and business location The building already spreads out over 35,000 square feet and hosts 25 employees.